# A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

> **NCT01735422** · PHASE2 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 67 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** r-hFSH
- **DRUG:** r-hLH
- **DRUG:** u-hCG

## Key facts

- **NCT ID:** NCT01735422
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** 2001-07
- **Final completion:** 2001-07
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735422, "A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01735422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*